AlloSource - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
AlloSource is a nonprofit cellular and tissue provider. It promotes human tissue donation and develops, processes and distributes precise bone, skin, soft-tissue and custom-machined allografts that are used in a number of medical treatments. The company’s products include osteobiologics grafts, general orthopedic grafts, spinal grafts, amniotic membrane, sports medicine grafts, large reconstructive grafts, burn care and wound care allografts. AlloSource products are used in various medical treatments including knee replacement, eye surgery, bone grafts, spinal fusions, and skin grafts for the severely burned. The company serves network of surgeons, partners and organ procurement organizations. It has a presence across the US including Colorado, New York, Illinois, Ohio, Texas, California, and Missouri. AlloSource is headquartered in Centennial, Colorado, the US.
AlloSource Key Recent Developments
Jan 16,2018: AlloSource Co-Authors International Space Station Microbial Study with NASA's Jet Propulsion Laboratory Jan 16, 2018
Dec 14,2017: AlloSource Announces Raime Leeby Muhle As Chief Financial Officer
Nov 07,2017: Allosource Announces Bob Lay As Chief Operating Officer
Mar 09,2017: Theracell And Allosource Announce Second Patent For Bone Fiber Technology